| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO | Director | CEO
1 company
Collier Alan Brian is a CEO at ENDONOVO THERAPEUTICS, INC.. Recent SEC Form 4 filings include 112 buys and 0 sells.
Estimated insider holdings value: $3 based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 7, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 38,000 | $0.03 | $984.80 | - | |
| Jan 31, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 46,000 | $0.03 | $1,188.30 | - | |
| Jan 29, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 59,000 | $0.03 | $1,696.40 | - | |
| Jan 25, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 120,500 | $0.03 | $3,305.95 | - | |
| Jan 22, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 65,500 | $0.03 | $1,773.95 | - | |
| Jan 16, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 161,500 | $0.03 | $5,056.30 | - | |
| Jan 14, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 45,000 | $0.03 | $1,487.00 | - | |
| Jan 9, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 1,045,000 | $0.00 | $852.00 | +0.7% |